Emergent BioSolutions Inc. (NYSE:EBS)

Sunday, June 8, 2025, 12:00 AM
Behind the Scenes with TGEN, a Data Center Detour, and the InfoArb Edge for Earnings Hunters [GeoWire Weekly No. 190] | TGEN [New Data Center Stock] CSBR MOJO OCC PXHI
Sunday, May 11, 2025, 4:29 PM
Real Signals, Not Just Hype: A Deep-Dive Open Forum Event [GeoWire Weekly No. 186] | TGEN ACFN PSIX CURI FSI FALC MOJO VMD FTK MUEL BURCA CSBR BLM.V
Sunday, November 17, 2024, 3:27 PM
5 Stock Pitches From MS Microcaps’ Starting Five Virtual Conference #2 [GeoWire Weekly No. 162]
See All GeoWire Weekly...
Emergent BioSolutions Inc. is a biopharmaceutical company that offers specialized products to healthcare providers and governments to address medical needs and emerging health threats. The Company develops, manufactures and delivers a portfolio of medical countermeasures primarily for government agencies in the areas of biological and chemical threats and emerging infectious diseases (EID). It also develops and commercializes therapeutics in areas of hematology/oncology, transplantation, infectious diseases and autoimmune disorders. Its two operating divisions include Biodefense and Biosciences. The Biodefense division is a pharmaceutical business focused on countermeasures that address public health threats, including chemical, biological, radiological, nuclear and explosives (CBRNE) threats, as well as EID. The Biosciences division is a pharmaceutical business focused on therapeutics in hematology/oncology with secondary on transplantation, infectious disease and autoimmunity.

Web site: http://www.emergentbiosolutions.com

Last updated October 4, 2016


Market Data powered by QuoteMedia. Terms of Use